Timothy Block
Directeur/Membre du Conseil chez HEPION PHARMACEUTICALS, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Timothy Block
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 26/11/2013 | - |
| Independent Dir/Board Member | 26/11/2013 | - | |
| Hepatitis B Foundation | Fondateur | - | - |
| President | - | - | |
| Drexel University College of Medicine | Corporate Officer/Principal | - | - |
| Pennsylvania Biotechnology Center of Bucks County | Directeur Général | - | - |
| President | - | - | |
| Baruch S. Blumberg Institute | Fondateur | - | - |
| President | - | - | |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Consultant / Advisor | - | - |
| Fondateur | - | - |
Historique de carrière de Timothy Block
Anciens postes connus de Timothy Block
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Founder | 4 |
| President | 3 |
| Director/Board Member | 2 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Hepatitis B Foundation | |
| Pennsylvania Biotechnology Center of Bucks County | |
| Baruch S. Blumberg Institute | |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
Hatch Biofund Management LLC
Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
- Bourse
- Insiders
- Timothy Block
- Expérience
